Categories Earnings, Health Care

Achieve Life Sciences (ACHV): Q4 2019 Earnings Snapshot

— Achieve Life Sciences (NASDAQ: ACHV) reported Q4 2019 net loss of $3.2 million, or $0.30 per share, compared to a loss of $3.6 million, or $0.55 per share, last year.   

— Total operating expenses were $3.2 million.

— At December 31, 2019, cash, cash equivalents and restricted cash was $16.7 million.

— Achieve Life Sciences completed a meeting with the US FDA to finalize the Phase 3 cytisinicline clinical development program.  

— The company established an agreement with the FreeMind Group to assist in securing non-dilutive funding to evaluate cytisinicline in vapers and e-cigarette users.  

— The company closed an underwritten public offering for gross proceeds of $13.8 million, before underwriting discounts and commissions and offering expenses.  

— ACHV shares were up 12.7% in premarket hours on Friday.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

What to expect when Domino’s Pizza (DPZ) reports Q2 2025 results

Domino’s Pizza, Inc. (NASDAQ: DPZ) is expected to report second-quarter 2025 results on July 21, before the opening bell, with the market looking for signs of momentum following the pizza

Here are a few reasons to be optimistic about Chewy (CHWY)

Shares of Chewy, Inc. (NYSE: CHWY) stayed red on Friday. The stock has gained 10% over the past three months. The pet products retailer has been performing well with top

Important takeaways from Conagra Brands’ Q4 2025 report

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported weaker-than-expected sales and adjusted earnings for its fourth quarter, reflecting ongoing economic uncertainty and muted consumer spending.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top